GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » ContextVision AB (OSTO:COVo) » Definitions » Research & Development

ContextVision AB (OSTO:COVO) Research & Development : kr0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is ContextVision AB Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. ContextVision AB's Research & Development for the three months ended in Mar. 2024 was kr0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.0 Mil.

ContextVision AB Research & Development Historical Data

The historical data trend for ContextVision AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ContextVision AB Research & Development Chart

ContextVision AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

ContextVision AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ContextVision AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ContextVision AB  (OSTO:COVo) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

ContextVision AB Research & Development Related Terms

Thank you for viewing the detailed overview of ContextVision AB's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

ContextVision AB (OSTO:COVO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » ContextVision AB (OSTO:COVo) » Definitions » Research & Development
Comparable Companies
OSL:OMDA OSL:CODE OSL:CARA OSL:INDCT OSL:NORDH VEEV GEHC TSE:2413 HQY ASX:PME RCM TXG DOCS PGNY EVH HKSE:01833 TDOC PRVA PINC SZSE:300253
Traded in Other Exchanges
CONTX:Norway
Address
Klara Norra Kyrkogata 31, Stockholm, SWE, SE-111 22
Website
https://www.contextvision.com
ContextVision AB is a Sweden-based medical technology company. It develops and sells image enhancement software for medical diagnosis and artificial intelligence. Its product portfolio includes image enhancement software for 2D/3D/4D (dimensional) ultrasound, magnetic resonance imaging (MRI), X-Ray, radiography, and mammography. its geographical segments are Asia, Europe, and America.

ContextVision AB (OSTO:COVO) Headlines

No Headlines